Hirochika Makino Selected Research

Hirochika Makino Research Topics

Disease

43	Stomach Neoplasms (Stomach Cancer) 09/2022 - 03/2008
13	Neoplasms (Cancer) 11/2015 - 08/2007
9	Neoplasm Metastasis (Metastasis) 09/2022 - 08/2007
7	Esophageal Neoplasms (Esophageal Cancer) 10/2015 - 01/2008
4	Lymphatic Metastasis 09/2022 - 08/2007
4	Pancreatic Fistula (Pancreatic Fistulas) 04/2016 - 08/2007
4	Colorectal Neoplasms (Colorectal Cancer) 06/2015 - 04/2008
4	Carcinoma (Carcinomatosis) 01/2015 - 08/2007
4	Liver Failure 07/2011 - 08/2005
3	Hemorrhage 11/2015 - 04/2008
2	Disease Progression 11/2017 - 04/2008
2	Inflammation (Inflammations) 04/2015 - 01/2012
2	Obesity 08/2010 - 04/2008
2	Anastomotic Leak 09/2009 - 01/2008
1	Infections 09/2022
1	Cholangitis 04/2017
1	Cholelithiasis 04/2017
1	Cholecystitis 04/2017
1	Malnutrition (Nutritional Deficiencies) 10/2015
1	Ascites 01/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2014
1	Colic (Abdominal Cramps) 11/2013
1	Pyloric Stenosis 11/2013
1	Abscess 09/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2008
1	Fistula 10/2008
1	Neutropenia 07/2008
1	Flatulence 06/2008
1	Carcinogenesis 04/2008
1	Adenocarcinoma 08/2007
1	Fatty Liver 02/2006
1	Liver Diseases (Liver Disease) 02/2006

Drug/Important Bio-Agent (IBA)

13	Docetaxel (Taxotere)FDA Link 10/2018 - 07/2008
5	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 01/2009
5	S 1 (combination)IBA 02/2013 - 07/2008
3	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 01/2009
2	S-1 plus cisplatinIBA 11/2017 - 01/2015
2	Leucovorin (Folinic Acid)FDA Link 06/2015 - 05/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2015 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 05/2008 - 04/2008
2	Messenger RNA (mRNA)IBA 05/2008 - 04/2008
1	ErbB Receptors (EGF Receptor)IBA 11/2017
1	Capecitabine (Xeloda)FDA Link 11/2017
1	human ERBB2 proteinIBA 11/2017
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2015
1	Collagen Type IV (Type IV Collagen)IBA 05/2015
1	Indicators and Reagents (Reagents)IBA 05/2015
1	ThrombomodulinIBA 04/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Biological ProductsIBA 08/2014
1	titanium silicide (TS-1)IBA 04/2013
1	AlbuminsIBA 01/2012
1	C-Reactive ProteinIBA 01/2012
1	Complementary DNA (cDNA)IBA 07/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 06/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2009
1	Alprostadil (Muse)FDA LinkGeneric 01/2009
1	Cyclin CIBA 01/2009
1	Cyclin D1IBA 01/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2008
1	Cysteine (L-Cysteine)FDA Link 05/2008
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2008
1	Matrix Metalloproteinases (MMPs)IBA 05/2008
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2008
1	Actins (F Actin)IBA 05/2008
1	ClaudinsIBA 04/2008
1	Claudin-1IBA 04/2008
1	Plasminogen Activator Inhibitor 1IBA 11/2007
1	Transaminases (Aminotransferases)IBA 02/2006
1	AcidsIBA 02/2006

Therapy/Procedure

29	Gastrectomy 09/2022 - 08/2007
14	Drug Therapy (Chemotherapy) 11/2015 - 03/2008
12	Therapeutics 11/2017 - 07/2008
8	Lymph Node Excision (Lymph Node Dissection) 04/2016 - 08/2007
5	Hepatectomy 07/2011 - 08/2005
4	Splenectomy 09/2022 - 08/2007
4	Neoadjuvant Therapy 10/2018 - 02/2014
4	Combination Drug Therapy (Combination Chemotherapy) 10/2015 - 10/2009
4	Esophagectomy 11/2011 - 01/2008
3	Adjuvant Chemotherapy 04/2013 - 02/2010
2	Cholecystectomy 10/2017 - 04/2017
2	Laparotomy 11/2015 - 11/2013
2	Chemoradiotherapy 10/2015 - 01/2009
2	Operative Surgical Procedures 04/2011 - 10/2008
1	Operative Time 09/2022
1	Length of Stay 09/2022
1	Gastroenterostomy 04/2017
1	Pancreatectomy 04/2016
1	Stents 11/2015
1	Nutritional Support (Artificial Feeding) 10/2015
1	Enteral Nutrition (Feeding, Tube) 10/2015
1	Aftercare (After-Treatment) 11/2013
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2013
1	Conversion to Open Surgery 09/2009
1	Radiotherapy 11/2008
1	Liver Transplantation 02/2006